Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kearns, CF; McKeever, KH; Malinowski, K; Struck, MB; Abe, T
   Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent
   JOURNAL OF APPLIED PHYSIOLOGY
   
   C.F. Kearns et al., "Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent", J APP PHYSL, 91(5), 2001, pp. 2064-2070
2. Kitaura, T; Tsunekawa, N; Hatta, H
   Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol
   JOURNAL OF APPLIED PHYSIOLOGY
   
   T. Kitaura et al., "Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol", J APP PHYSL, 91(1), 2001, pp. 85-90
3. Oliver, P; Pico, C; Palou, A
   Differential expression of genes for uncoupling proteins 1, 2 and 3 in brown and white adipose tissue depots during rat development
   CELLULAR AND MOLECULAR LIFE SCIENCES
   
   P. Oliver et al., "Differential expression of genes for uncoupling proteins 1, 2 and 3 in brown and white adipose tissue depots during rat development", CELL MOL L, 58(3), 2001, pp. 470-476
4. de Souza, CJ; Burkey, BF
   Beta(3)-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans
   CURRENT PHARMACEUTICAL DESIGN
   
   C.J. de Souza e B.F. Burkey, "Beta(3)-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans", CUR PHARM D, 7(14), 2001, pp. 1433-1449
5. Satpathy, BB; Mukherjee, D; Ray, AK
   Effects of dietary inclusion of the beta-adrenergic agonist, salbutamol, on growth performance and whole-body composition of rohu Labeo rohita (Hamilton) fingerlings fed diets containing two protein levels
   AQUACULTURE RESEARCH
   
   B.B. Satpathy et al., "Effects of dietary inclusion of the beta-adrenergic agonist, salbutamol, on growth performance and whole-body composition of rohu Labeo rohita (Hamilton) fingerlings fed diets containing two protein levels", AQUAC RES, 32(9), 2001, pp. 739-747
6. Walter, MC; Lochmuller, H
   Novel approaches to treat muscular dystrophies
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   M.C. Walter e H. Lochmuller, "Novel approaches to treat muscular dystrophies", EXPERT OP I, 10(4), 2001, pp. 695-707
7. Gomez-Ambrosi, J; Fruhbeck, G; Aguado, M; Milagro, FI; Margareto, J; Martinez, AJ
   Divergent effects of an alpha(2)-adrenergic antagonist on lipolysis and thermogenesis: Interactions with a beta(3)-adrenergic agonist in rats
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   J. Gomez-Ambrosi et al., "Divergent effects of an alpha(2)-adrenergic antagonist on lipolysis and thermogenesis: Interactions with a beta(3)-adrenergic agonist in rats", INT J MOL M, 8(1), 2001, pp. 103-109
8. Dahl, R; Greefhorst, LAPM; Nowak, D; Nonikov, V; Byrne, AM; Thomson, MH; Till, D; Della Cioppa, G
   Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
   
   R. Dahl et al., "Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease", AM J R CRIT, 164(5), 2001, pp. 778-784
9. Davis, MS; Freed, AN
   Repeated hyperventilation causes peripheral airways inflammation, hyperreactivity, and impaired bronchodilation in dogs
   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
   
   M.S. Davis e A.N. Freed, "Repeated hyperventilation causes peripheral airways inflammation, hyperreactivity, and impaired bronchodilation in dogs", AM J R CRIT, 164(5), 2001, pp. 785-789
10. Nielsen, KG; Bisgaard, H
    Bronchodilation and bronchoprotection in asthmatic preschool children fromformoterol administered by mechanically actuated dry-powder inhaler and spacer
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    K.G. Nielsen e H. Bisgaard, "Bronchodilation and bronchoprotection in asthmatic preschool children fromformoterol administered by mechanically actuated dry-powder inhaler and spacer", AM J R CRIT, 164(2), 2001, pp. 256-259
11. Haughey, SA; Baxter, GA; Elliot, CT; Persson, B; Jonson, C; Bjurling, P
    Determination of clenbuterol residues in bovine urine by optical immunobiosensor assay
    JOURNAL OF AOAC INTERNATIONAL
    
    S.A. Haughey et al., "Determination of clenbuterol residues in bovine urine by optical immunobiosensor assay", J AOAC INT, 84(4), 2001, pp. 1025-1030
12. McGraw, DW; Fukuda, N; James, PF; Forbes, SL; Woo, AL; Lingrel, JB; Witte, DP; Matthay, MA; Liggett, SB
    Targeted transgenic expression of beta(2)-adrenergic receptors to type II cells increases alveolar fluid clearance
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    
    D.W. McGraw et al., "Targeted transgenic expression of beta(2)-adrenergic receptors to type II cells increases alveolar fluid clearance", AM J P-LUNG, 281(4), 2001, pp. L895-L903
13. Wyatt, TA; Sisson, JH
    Chronic ethanol downregulates PKA activation and ciliary beating in bovinebronchial epithelial cells
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    
    T.A. Wyatt e J.H. Sisson, "Chronic ethanol downregulates PKA activation and ciliary beating in bovinebronchial epithelial cells", AM J P-LUNG, 281(3), 2001, pp. L575-L581
14. Huang, YC; Wu, BN; Yeh, JL; Chen, SJ; Liang, JC; Lo, YC; Chen, IJ
    A new aspect of view in synthesizing new type beta-adrenoceptor blockers with ancillary antioxidant activities
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    Y.C. Huang et al., "A new aspect of view in synthesizing new type beta-adrenoceptor blockers with ancillary antioxidant activities", BIO MED CH, 9(7), 2001, pp. 1739-1746
15. Lynch, GS; Hinkle, RT; Faulkner, JA
    Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment
    NEUROMUSCULAR DISORDERS
    
    G.S. Lynch et al., "Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment", NEUROMUSC D, 11(2), 2001, pp. 192-196
16. Fotovati, A; Hayashi, T; Ito, T
    Lipolytic effect of BRL 35 135, a beta 3 agonist, and its interaction withdietary lipids on the accumulation of fats in rat body
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    
    A. Fotovati et al., "Lipolytic effect of BRL 35 135, a beta 3 agonist, and its interaction withdietary lipids on the accumulation of fats in rat body", J NUTR BIOC, 12(3), 2001, pp. 153-161
17. Berggren, F; Ekstrom, T
    A cost-effectiveness study comparing the as-needed use of formoterol (Oxis(R)) and terbutaline (Bricanyl (R)) in patients with moderate to severe asthma
    RESPIRATORY MEDICINE
    
    F. Berggren e T. Ekstrom, "A cost-effectiveness study comparing the as-needed use of formoterol (Oxis(R)) and terbutaline (Bricanyl (R)) in patients with moderate to severe asthma", RESP MED, 95(9), 2001, pp. 753-758
18. Andersson, F; Stahl, E; Barnes, PJ; Lofdahl, CG; O'Byrne, PM; Pauwels, RA; Postma, DS; Tattersfield, AE; Ullman, A
    Adding formoterol to budesonide in moderate asthma - health economic results from the FACET study
    RESPIRATORY MEDICINE
    
    F. Andersson et al., "Adding formoterol to budesonide in moderate asthma - health economic results from the FACET study", RESP MED, 95(6), 2001, pp. 505-512
19. Benhamou, D; Cuvelier, A; Muir, JF; Leclerc, V; Le Gros, V; Kottakis, J; Bourdeix, I
    Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil (R) Aerolizer (TM)) with salbutamol (Ventodisk (TM))
    RESPIRATORY MEDICINE
    
    D. Benhamou et al., "Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil (R) Aerolizer (TM)) with salbutamol (Ventodisk (TM))", RESP MED, 95(10), 2001, pp. 817-821
20. Sears, MR
    The evolution of beta(2)-agonists
    RESPIRATORY MEDICINE
    
    M.R. Sears, "The evolution of beta(2)-agonists", RESP MED, 95, 2001, pp. S2-S6
21. Lotvall, J
    Pharmacological similarities and differences between beta(2)-agonists
    RESPIRATORY MEDICINE
    
    J. Lotvall, "Pharmacological similarities and differences between beta(2)-agonists", RESP MED, 95, 2001, pp. S7-S11
22. Andrea, P; Miroslav, S; Silvia, S; Stanislav, M
    A solid binding matrix/molecularly imprinted polymer-based sensor system for the determination of clenbuterol in bovine liver using differential-pulse voltammetry
    SENSORS AND ACTUATORS B-CHEMICAL
    
    P. Andrea et al., "A solid binding matrix/molecularly imprinted polymer-based sensor system for the determination of clenbuterol in bovine liver using differential-pulse voltammetry", SENS ACTU-B, 76(1-3), 2001, pp. 286-294
23. Nakamura, Y; Nagase, I; Asano, A; Sasaki, N; Yoshida, T; Umekawa, T; Sakane, N; Saito, M
    beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse
    JOURNAL OF VETERINARY MEDICAL SCIENCE
    
    Y. Nakamura et al., "beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse", J VET MED S, 63(3), 2001, pp. 309-314
24. Huang, MT; Yang, YH; Tin, YT; Lu, MY; Wang, LH; Tsai, MJ; Chiang, BL
    beta 2-agonist exerts differential effects on the development of cord blood T cells but not on peripheral blood T cells
    PEDIATRIC ALLERGY AND IMMUNOLOGY
    
    M.T. Huang et al., "beta 2-agonist exerts differential effects on the development of cord blood T cells but not on peripheral blood T cells", PEDIAT A IM, 12(1), 2001, pp. 17-20
25. Korn, SH; Jerre, A; Brattsand, R
    Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells
    EUROPEAN RESPIRATORY JOURNAL
    
    S.H. Korn et al., "Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells", EUR RESP J, 17(6), 2001, pp. 1070-1077
26. Jones, SL; Cowan, JO; Flannery, EM; Hancox, RJ; Herbison, GP; Taylor, DR
    Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol
    EUROPEAN RESPIRATORY JOURNAL
    
    S.L. Jones et al., "Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol", EUR RESP J, 17(3), 2001, pp. 368-373
27. Shingo, S; Zhang, J; Reiss, TF
    Correlation of airway obstruction and patient-reported endpoints in clinical studies
    EUROPEAN RESPIRATORY JOURNAL
    
    S. Shingo et al., "Correlation of airway obstruction and patient-reported endpoints in clinical studies", EUR RESP J, 17(2), 2001, pp. 220-224
28. Smith, DJ
    Untitled
    CHIRALITY
    
    D.J. Smith, "Untitled", CHIRALITY, 13(6), 2001, pp. 279-280
29. Fisher, AL; DePuy, E; Shih, T; Stearns, R; Lee, Y; Gottesdiener, K; Flattery, S; De Smet, M; Keymeulen, B; Musson, DG
    Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    A.L. Fisher et al., "Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation", J PHARM B, 26(5-6), 2001, pp. 739-752
30. Wang, AQ; Fisher, AL; Hsieh, J; Cairns, AM; Rogers, JD; Musson, DG
    Determination of a beta(3)-agonist in human plasma by LC/MS/MS with semi-automated 48-well diatomaceous earth plate
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    A.Q. Wang et al., "Determination of a beta(3)-agonist in human plasma by LC/MS/MS with semi-automated 48-well diatomaceous earth plate", J PHARM B, 26(3), 2001, pp. 357-365
31. Leenen, FHH; White, R; Yuan, BX
    Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    
    F.H.H. Leenen et al., "Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system", AM J P-HEAR, 281(6), 2001, pp. H2410-H2416
32. Buck, H; Parry-Billings, M
    Discriminating measures of bronchodilator drug efficacy and potency
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    H. Buck e M. Parry-Billings, "Discriminating measures of bronchodilator drug efficacy and potency", BR J CL PH, 52(3), 2001, pp. 245-253
33. Gomez-Ambrosi, J; Fruhbeck, G; Martinez, AJ
    Rapid in vivo PGC-1 mRNA upregulation in brown adipose tissue of Wistar rats by a beta(3)-adrenergic agonist and lack of effect of leptin
    MOLECULAR AND CELLULAR ENDOCRINOLOGY
    
    J. Gomez-Ambrosi et al., "Rapid in vivo PGC-1 mRNA upregulation in brown adipose tissue of Wistar rats by a beta(3)-adrenergic agonist and lack of effect of leptin", MOL C ENDOC, 176(1-2), 2001, pp. 85-90
34. Cabrol, D; Gillet, JY; Madelenat, P; Lansac, J; Paniel, B; Dellenbach, P; Lemoine, JP; Bronstein, R; Leng, JJ; Laurent, MC; Mares, P; Hedon, B; Magnin, G; Treisser, A; Schumacher, JC; Grosieux, P; Jacquetin, P; Bruhat, M; Segard, L; Puech, F; Engelmann, P; Schweitzer, M; Boog, G; Boubli, L; Duquidt, N; Desroches, A; Blot, P; Milliez, J; Tabaste, JL; MacLennan, AH; Crowther, C; Dickinson, JE; Peat, BB; King, J; Fulcher, IR; Permezel, JM
    Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    D. Cabrol et al., "Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol", EUR J OB GY, 98(2), 2001, pp. 177-185
35. Yeh, JL; Tsai, CH; Liang, JC; Wu, JR; Huang, YC; Chen, IJ
    Third-generation dihydropyridine-type calcium channel blocker labedipinedilol-B displays alpha/beta-adrenoceptor blocking activities
    DRUG DEVELOPMENT RESEARCH
    
    J.L. Yeh et al., "Third-generation dihydropyridine-type calcium channel blocker labedipinedilol-B displays alpha/beta-adrenoceptor blocking activities", DRUG DEV R, 52(3), 2001, pp. 462-474
36. Kim, KH; Kim, HJ; Jeun, EY; Seo, SH; Hong, SP; Kang, JS; Youm, JR; Lee, SC
    Chiral separation of beta(2)-agonists by capillary electrophoresis using hydroxypropyl-alpha-cyclodextrin as a chiral selector
    ARCHIVES OF PHARMACAL RESEARCH
    
    K.H. Kim et al., "Chiral separation of beta(2)-agonists by capillary electrophoresis using hydroxypropyl-alpha-cyclodextrin as a chiral selector", ARCH PH RES, 24(4), 2001, pp. 281-285
37. Sneddon, AA; Delday, MI; Steven, J; Maltin, CA
    Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    A.A. Sneddon et al., "Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism", AM J P-ENDO, 281(4), 2001, pp. E676-E682
38. Sakuma, T; Tuchihara, C; Ishigaki, M; Osanai, K; Nambu, Y; Toga, H; Takahashi, K; Ohya, N; Inoue, M; Matthay, MA
    Beta(1)-adrenoceptor stimulation by high-dose terbutaline downregulates terbutaline-stimulated alveolar fluid clearance in ex vivo rat lung
    EXPERIMENTAL LUNG RESEARCH
    
    T. Sakuma et al., "Beta(1)-adrenoceptor stimulation by high-dose terbutaline downregulates terbutaline-stimulated alveolar fluid clearance in ex vivo rat lung", EXP LUNG R, 27(5), 2001, pp. 453-468
39. Kurabayashi, T; Tomita, M; Matsushita, H; Honda, A; Takakuwa, K; Tanaka, K
    Effects of a beta 3 adrenergic receptor agonist on bone and bone marrow adipocytes in the tibia and lumbar spine of the ovariectomized rat
    CALCIFIED TISSUE INTERNATIONAL
    
    T. Kurabayashi et al., "Effects of a beta 3 adrenergic receptor agonist on bone and bone marrow adipocytes in the tibia and lumbar spine of the ovariectomized rat", CALCIF TIS, 68(4), 2001, pp. 248-254
40. Klaus, S; Seivert, A; Boeuf, S
    Effect of the beta 3-adrenergic agonist Cl316,243 on functional differentiation of white and brown adipocytes in primary cell culture
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    
    S. Klaus et al., "Effect of the beta 3-adrenergic agonist Cl316,243 on functional differentiation of white and brown adipocytes in primary cell culture", BBA-MOL CEL, 1539(1-2), 2001, pp. 85-92
41. Canu, MH; Stevens, L; Ricart-Firinga, C; Picquet, F; Falempin, M
    Effect of the beta(2)-agonist clenbuterol on the locomotor activity of ratsubmitted to a 14-day period of hypodynamia-hypokinesia
    BEHAVIOURAL BRAIN RESEARCH
    
    M.H. Canu et al., "Effect of the beta(2)-agonist clenbuterol on the locomotor activity of ratsubmitted to a 14-day period of hypodynamia-hypokinesia", BEH BRA RES, 122(1), 2001, pp. 103-112
42. Condemi, JJ
    Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: A multicenter, randomized, open-labeltrial
    CLINICAL THERAPEUTICS
    
    J.J. Condemi, "Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: A multicenter, randomized, open-labeltrial", CLIN THER, 23(9), 2001, pp. 1529-1541
43. Chen, KD; Alway, SE
    Clenbuterol reduces soleus muscle fatigue during disuse in aged rats
    MUSCLE & NERVE
    
    K.D. Chen e S.E. Alway, "Clenbuterol reduces soleus muscle fatigue during disuse in aged rats", MUSCLE NERV, 24(2), 2001, pp. 211-222
44. Frerichs, O; Fansa, H; Ziems, P; Schneider, W; Keilhoff, G
    Regeneration of peripheral nerves after clenbuterol treatment in a rat model
    MUSCLE & NERVE
    
    O. Frerichs et al., "Regeneration of peripheral nerves after clenbuterol treatment in a rat model", MUSCLE NERV, 24(12), 2001, pp. 1687-1691
45. Jartti, T
    Asthma, asthma medication and autonomic nervous system dysfunction
    CLINICAL PHYSIOLOGY
    
    T. Jartti, "Asthma, asthma medication and autonomic nervous system dysfunction", CLIN PHYSL, 21(2), 2001, pp. 260-269
46. Moneret-Vautrin, DA; Kanny, G; Morisset, M; Flabbee, J; Guenard, L; Beaudouin, E; Parisot, L
    Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit
    ALLERGY
    
    D.A. Moneret-Vautrin et al., "Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit", ALLERGY, 56(11), 2001, pp. 1071-1076
47. Verago, JL; Grassi-Kassisse, DM; Spadari-Bratfisch, RC
    Metabolic markers following beta-adrenoceptor agonist infusion in footshock-stressed rats
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    J.L. Verago et al., "Metabolic markers following beta-adrenoceptor agonist infusion in footshock-stressed rats", BRAZ J MED, 34(9), 2001, pp. 1197-1207
48. Matz, J; Emmett, A; Rickard, K; Kalberg, C
    Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    J. Matz et al., "Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations", J ALLERG CL, 107(5), 2001, pp. 783-789
49. Collins, S; Surwit, RS
    The beta-adrenergic receptors and the control of adipose tissue metabolismand thermogenesis
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56
    
    S. Collins e R.S. Surwit, "The beta-adrenergic receptors and the control of adipose tissue metabolismand thermogenesis", REC PROG H, 56, 2001, pp. 309-328
50. Partridge, MR
    The profile of respiratory conditions: why government action is necessary
    THORAX
    
    M.R. Partridge, "The profile of respiratory conditions: why government action is necessary", THORAX, 56(10), 2001, pp. 744-745
51. Haahtela, T; Klaukka, T; Koskela, K; Erhola, M; Laitinen, LA
    Asthma programme in Finland: a community problem needs community solutions
    THORAX
    
    T. Haahtela et al., "Asthma programme in Finland: a community problem needs community solutions", THORAX, 56(10), 2001, pp. 806-814
52. Laurie, S; Khan, D
    Inhaled corticosteroids as first-line therapy for asthma - Why they work-and what the guidelines and evidence suggest
    POSTGRADUATE MEDICINE
    
    S. Laurie e D. Khan, "Inhaled corticosteroids as first-line therapy for asthma - Why they work-and what the guidelines and evidence suggest", POSTGR MED, 109(5), 2001, pp. 44
53. Konkar, AA; Nikulin, VI; De Los Angeles, J; Hong, SS; Fertel, RH; Miller, DD; Feller, DR
    Biochemical activities of trimetoquinol analogs at human beta(1) and beta(3)-adrenergic receptors
    PHARMACOLOGY
    
    A.A. Konkar et al., "Biochemical activities of trimetoquinol analogs at human beta(1) and beta(3)-adrenergic receptors", PHARMACOL, 62(1), 2001, pp. 45-55
54. Ojima, F; Nakamura, H; Ebihara, M; Shoji, T; Tomike, H; Nakagawa, Y
    Clinical characteristics of asthmatic patients prescribed various beta-agonist metered-dose inhalers at Yamagata University Hospital
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    
    F. Ojima et al., "Clinical characteristics of asthmatic patients prescribed various beta-agonist metered-dose inhalers at Yamagata University Hospital", YAKUGAKU ZA, 121(1), 2001, pp. 79-84
55. Kissel, JT; McDermott, MP; Mendell, JR; King, WM; Pandya, S; Griggs, RC; Tawil, R; Cos, L; Langsam, A; Martens, B; Brower, C; Herr, BE; Figlewicz, D; Forrester, J; Downing, K; Holloway, RG; Hubble, J; Kolassa, J
    Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy
    NEUROLOGY
    
    J.T. Kissel et al., "Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy", NEUROLOGY, 57(8), 2001, pp. 1434-1440
56. Han, NLR; Haddrill, JL; Lynch, JW
    Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the beta-amino acid agonist, taurine
    JOURNAL OF NEUROCHEMISTRY
    
    N.L.R. Han et al., "Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the beta-amino acid agonist, taurine", J NEUROCHEM, 79(3), 2001, pp. 636-647
57. Marunaka, Y; Niisato, N
    The essential role of cytosolic Cl- in Ca2+ regulation of an amiloride-sensitive channel in fetal rat pneumocyte
    JOURNAL OF MEMBRANE BIOLOGY
    
    Y. Marunaka e N. Niisato, "The essential role of cytosolic Cl- in Ca2+ regulation of an amiloride-sensitive channel in fetal rat pneumocyte", J MEMBR BIO, 180(1), 2001, pp. 91-99
58. Tsuchiya, Y; Suzuki, Y
    The effect of cAMP on electrogenic Na+ absorption in the rat distal colon
    JAPANESE JOURNAL OF PHYSIOLOGY
    
    Y. Tsuchiya e Y. Suzuki, "The effect of cAMP on electrogenic Na+ absorption in the rat distal colon", JPN J PHYSL, 51(4), 2001, pp. 435-444
59. Inagaki, N; Nagai, H
    Drugs for the treatment of allergic diseases
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    N. Inagaki e H. Nagai, "Drugs for the treatment of allergic diseases", JPN J PHARM, 86(3), 2001, pp. 275-280
60. Haugen, F; Jorgensen, A; Drevon, CA; Trayhurn, P
    Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes
    FEBS LETTERS
    
    F. Haugen et al., "Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes", FEBS LETTER, 507(1), 2001, pp. 105-108
61. Green, SA; Rathz, DA; Schuster, AJ; Liggett, SB
    The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s)
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    S.A. Green et al., "The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s)", EUR J PHARM, 421(3), 2001, pp. 141-147
62. Susulic, VS; LaVallette, L; Duzic, E; Chen, L; Shuey, D; Karathanasis, SK; Steiner, KE
    Expression of the human beta(3)-adrenergic receptor gene in SK-N-MC cells is under the control of a distal enhancer
    ENDOCRINOLOGY
    
    V.S. Susulic et al., "Expression of the human beta(3)-adrenergic receptor gene in SK-N-MC cells is under the control of a distal enhancer", ENDOCRINOL, 142(5), 2001, pp. 1935-1949
63. Fish, JE; Israel, E; Murray, JJ; Emmett, A; Boone, R; Yancey, SW; Rickard, KA
    Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy
    CHEST
    
    J.E. Fish et al., "Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy", CHEST, 120(2), 2001, pp. 423-430
64. Giannini, D; Di Franco, A; Bacci, E; Dente, FL; Bartoli, ML; Vagaggini, B; Paggiaro, P
    Tolerance to the protective effect of salmeterol on allergen challenge canbe partially restored by the withdrawal of salmeterol regular treatment
    CHEST
    
    D. Giannini et al., "Tolerance to the protective effect of salmeterol on allergen challenge canbe partially restored by the withdrawal of salmeterol regular treatment", CHEST, 119(6), 2001, pp. 1671-1675
65. D'Urzo, AD; De Salvo, MC; Ramirez-Rivera, A; Almeida, J; Sichletidis, L; Rapatz, G; Kottakis, J
    In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium - A 3-week, randomized, double-blind, within-patient, multicenter study
    CHEST
    
    A.D. D'Urzo et al., "In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium - A 3-week, randomized, double-blind, within-patient, multicenter study", CHEST, 119(5), 2001, pp. 1347-1356
66. Ream, RS; Loftis, LL; Albers, GM; Becker, BA; Lynch, RE; Mink, RB
    Efficacy of IV theophylline in children with severe status asthmaticus
    CHEST
    
    R.S. Ream et al., "Efficacy of IV theophylline in children with severe status asthmaticus", CHEST, 119(5), 2001, pp. 1480-1488
67. Braganza, JM
    Towards a novel treatment strategy for acute pancreatitis - 2. Principles and potential practice
    DIGESTION
    
    J.M. Braganza, "Towards a novel treatment strategy for acute pancreatitis - 2. Principles and potential practice", DIGESTION, 63(3), 2001, pp. 143-162
68. Gu, JM; He, QJ; Gao, Q; Wang, HL; Huo, L; Wang, Q; Wang, ZS; Li, SQ; Tan, MQ; Zhang, FC; You, JH; Yamamoto, M
    Open-label, uncontrolled clinical study of formoterol, a selective beta(2)-receptor agonist, in patients with bronchial asthma and asthmatic bronchitis
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    
    J.M. Gu et al., "Open-label, uncontrolled clinical study of formoterol, a selective beta(2)-receptor agonist, in patients with bronchial asthma and asthmatic bronchitis", CURR THER R, 62(7), 2001, pp. 530-537
69. Yanagi, T; Kikuchi, K; Takeuchi, H; Ishikawa, T; Nishimura, T; Yamamoto, I
    The practical synthesis of a uterine relaxant, bis(2-{[(2S)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)-phenyl]ethyl}amino)-1,2,3,4-tetrahydronaphthalen-7-yl]oxy}-N,N-dimethylacetamide) sulfate (KUR-1246)
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    T. Yanagi et al., "The practical synthesis of a uterine relaxant, bis(2-{[(2S)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)-phenyl]ethyl}amino)-1,2,3,4-tetrahydronaphthalen-7-yl]oxy}-N,N-dimethylacetamide) sulfate (KUR-1246)", CHEM PHARM, 49(8), 2001, pp. 1018-1023
70. Matsuo, K; Yamamoto, Y; Kado, N; Yamazaki, M; Nagata, O; Kato, H; Tsuji, A
    Racemization kinetics of meluadrine tartrate in aqueous solution
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    K. Matsuo et al., "Racemization kinetics of meluadrine tartrate in aqueous solution", CHEM PHARM, 49(1), 2001, pp. 101-104
71. Spicuzza, L; Belvisi, MG; Birrell, MA; Barnes, PJ; Hele, DJ; Giembycz, MA
    Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase
    BRITISH JOURNAL OF PHARMACOLOGY
    
    L. Spicuzza et al., "Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase", BR J PHARM, 133(8), 2001, pp. 1201-1212
72. Irie, K; Fujii, E; Ishida, H; Wada, K; Suganuma, T; Nishikori, T; Yoshioka, T; Muraki, T
    Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin
    BRITISH JOURNAL OF PHARMACOLOGY
    
    K. Irie et al., "Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin", BR J PHARM, 133(2), 2001, pp. 237-242
73. Finney, PA; Donnelly, LE; Belvisi, MG; Chuang, TT; Birrell, M; Harris, A; Mak, JCW; Scorer, C; Barnes, PJ; Adcock, IM; Giembycz, MA
    Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha)
    BRITISH JOURNAL OF PHARMACOLOGY
    
    P.A. Finney et al., "Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha)", BR J PHARM, 132(6), 2001, pp. 1261-1270
74. Margareto, J; Larrarte, E; Marti, A; Martinez, AJ
    Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPAR gamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta 3-adrenergic agonist
    BIOCHEMICAL PHARMACOLOGY
    
    J. Margareto et al., "Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPAR gamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta 3-adrenergic agonist", BIOCH PHARM, 61(12), 2001, pp. 1471-1478
75. Meenagh, SA; Elliott, CT; Buick, RK; Izeboud, CA; Witkamp, RF
    The preparation, solubilisation and binding characteristics of a beta 2-adrenoceptor isolated from transfected Chinese hamster cells
    ANALYST
    
    S.A. Meenagh et al., "The preparation, solubilisation and binding characteristics of a beta 2-adrenoceptor isolated from transfected Chinese hamster cells", ANALYST, 126(4), 2001, pp. 491-494
76. Fisk, NM; Calder, AA; Cameron, AD; Elder, MG; Fusi, L; Greer, IA; Lamont, RF; Mason, GC; Owen, E; Steer, PJ; Tuffnell, DJ; Walker, J; Marsal, K; Ekman-Ordeberg, G; Gudmundsson, S; Ingemarsson, I; Lyrenas, S; Mattsson, LA; Molin, A; Thomassen, P; Wennergren, M; Weber, T; Andersen, LF; Lyndrup, J; Presl, J; Bouda, J; Cech, E; Koliba, P; Kucera, P; Kudela, M; Pilka, L; Unzeitig, V; Zivny, J
    The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor - A randomized, double-blind, controlled study
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    
    N.M. Fisk et al., "The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor - A randomized, double-blind, controlled study", ACT OBST SC, 80(5), 2001, pp. 413-422
77. Zarkovic, JP; Marenk, M; Valovirta, E; Kuusela, AL; Sandahl, G; Persson, B; Olsson, H
    One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma
    PEDIATRIC PULMONOLOGY
    
    J.P. Zarkovic et al., "One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma", PEDIAT PULM, 29(6), 2000, pp. 424-429
78. Kuusela, AL; Marenk, M; Sandahl, G; Sanderud, J; Nikolajev, K; Persson, B; Olsson, H
    Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma
    PEDIATRIC PULMONOLOGY
    
    A.L. Kuusela et al., "Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma", PEDIAT PULM, 29(3), 2000, pp. 194-201
79. Collomp, K; Candau, R; Lasne, F; Labsy, Z; Prefaut, C; De Ceaurriz, J
    Effects of short-term oral salbutamol administration on exercise enduranceand metabolism
    JOURNAL OF APPLIED PHYSIOLOGY
    
    K. Collomp et al., "Effects of short-term oral salbutamol administration on exercise enduranceand metabolism", J APP PHYSL, 89(2), 2000, pp. 430-436
80. Chen, KJD; Alway, SE
    A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats
    JOURNAL OF APPLIED PHYSIOLOGY
    
    K.J.D. Chen e S.E. Alway, "A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats", J APP PHYSL, 89(2), 2000, pp. 606-612
81. Brooks, BR; Juhasz-Poscine, K; Waclawik, A; Sanjak, M; Belden, D; Roelke, K; Parnell, J; Weasler, C
    Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    B.R. Brooks et al., "Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists", AMYOTROPH L, 1, 2000, pp. 45-53
82. Norton, GR; Trifunovic, B; Woodiwiss, AJ
    Attenuated beta-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
    
    G.R. Norton et al., "Attenuated beta-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats", EUR J A PHY, 81(4), 2000, pp. 310-316
83. Hayashi, K; Saito, K; Kizawa, Y; Sano, M; Kusama, T; Iwamoto, K; Murakami, H
    Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    
    K. Hayashi et al., "Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats", COMP BIOC C, 126(2), 2000, pp. 123-128
84. Cepero, M; Perez-Pertejo, Y; Cubria, JC; Reguera, R; Balana-Fouce, R; Ordonez, C; Escudero, DO
    Muscle and serum changes with salbutamol administration in aerobically exercised rats
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    
    M. Cepero et al., "Muscle and serum changes with salbutamol administration in aerobically exercised rats", COMP BIOC C, 126(1), 2000, pp. 45-51
85. Moibi, JA; Christopherson, RJ; Li, YZ
    Effect of beta-adrenergic agonist L-644,969 on the impact of the thermal environment on in vitro fatty acid synthesis and lipogenic enzymes in sheep
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    
    J.A. Moibi et al., "Effect of beta-adrenergic agonist L-644,969 on the impact of the thermal environment on in vitro fatty acid synthesis and lipogenic enzymes in sheep", COMP BIOC C, 125(2), 2000, pp. 251-263
86. Proietto, J; Fam, BC; Ainslie, DA; Thorburn, AW
    Novel anti-obesity drugs
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    J. Proietto et al., "Novel anti-obesity drugs", EXPERT OP I, 9(6), 2000, pp. 1317-1326
87. Laight, DW
    Therapeutic approaches to insulin resistance
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    D.W. Laight, "Therapeutic approaches to insulin resistance", EXPERT OP T, 10(11), 2000, pp. 1703-1709
88. Simon, E; Fernandez-Quintela, A; Portillo, MD; Del Barrio, AS
    Effects of medium-chain fatty acids on body composition and protein metabolism in overweight rats
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
    
    E. Simon et al., "Effects of medium-chain fatty acids on body composition and protein metabolism in overweight rats", J PHYSIOL B, 56(4), 2000, pp. 337-346
89. Damasceno, L; Ventura, R; Ortuno, J; Segura, J
    Derivatization procedures for the detection of beta(2)-agonists by gas chromatographic/mass spectrometric analysis
    JOURNAL OF MASS SPECTROMETRY
    
    L. Damasceno et al., "Derivatization procedures for the detection of beta(2)-agonists by gas chromatographic/mass spectrometric analysis", J MASS SPEC, 35(11), 2000, pp. 1285-1294
90. Niu, TH; Rogus, JJ; Chen, CZ; Wang, BY; Yang, JH; Fang, ZA; Weiss, ST; Xu, XP
    Familial aggregation of bronchodilator response - A community-based study
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    T.H. Niu et al., "Familial aggregation of bronchodilator response - A community-based study", AM J R CRIT, 162(5), 2000, pp. 1833-1837
91. Israel, E; Drazen, JM; Liggett, SB; Boushey, HA; Cherniack, RM; Chinchilli, VM; Cooper, DM; Fahy, JV; Fish, JE; Ford, JG; Kraft, M; Kunselman, S; Lazarus, SC; Lemanske, RF; Martin, RJ; McLean, DE; Peters, SP; Silverman, EK; Sorkness, CA; Szefler, SJ; Weiss, ST; Yandava, CN
    The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    E. Israel et al., "The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma", AM J R CRIT, 162(1), 2000, pp. 75-80
92. Aldridge, RE; Hancox, RJ; Taylor, DR; Cowan, JO; Winn, MC; Frampton, CM; Town, GI
    Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    R.E. Aldridge et al., "Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma", AM J R CRIT, 161(5), 2000, pp. 1459-1464
93. Malamas, MS; Largis, E; Gunawan, I; Li, ZN; Tillett, J; Han, SCH; Mulvey, R
    Potent, selective aminothiazolidinediones agonists of the human beta(3) adrenergic receptor
    MEDICINAL CHEMISTRY RESEARCH
    
    M.S. Malamas et al., "Potent, selective aminothiazolidinediones agonists of the human beta(3) adrenergic receptor", MED CHEM RE, 10(3), 2000, pp. 164-177
94. Suzuki, H; Ueno, A; Takei, M; Shindo, K; Higa, T; Fukamachi, H
    The effects of S1319, a novel marine sponge-derived beta(2)-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells
    INFLAMMATION RESEARCH
    
    H. Suzuki et al., "The effects of S1319, a novel marine sponge-derived beta(2)-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells", INFLAMM RES, 49(2), 2000, pp. 86-94
95. Harvie, MN; Campbell, IT
    Energy balance, cancer and the sympathetic nervous system
    EUROPEAN JOURNAL OF CANCER
    
    M.N. Harvie e I.T. Campbell, "Energy balance, cancer and the sympathetic nervous system", EUR J CANC, 36(3), 2000, pp. 289-292
96. Lynch, GS; Hinkle, RT; Faulkner, JA
    Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment
    EXPERIMENTAL PHYSIOLOGY
    
    G.S. Lynch et al., "Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment", EXP PHYSIOL, 85(3), 2000, pp. 295-299
97. Sawaya, WN; Lone, K; Husain, A; Dashti, B; Saeed, T
    Screening for beta-agonists in sheep urine and eyes by an enzyme-linked immunosorbent assay in the state of Kuwait
    FOOD CONTROL
    
    W.N. Sawaya et al., "Screening for beta-agonists in sheep urine and eyes by an enzyme-linked immunosorbent assay in the state of Kuwait", FOOD CONTRO, 11(1), 2000, pp. 1-5
98. Richter, B; Bender, R; Berger, M
    Effects of on-demand beta(2)-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial
    JOURNAL OF INTERNAL MEDICINE
    
    B. Richter et al., "Effects of on-demand beta(2)-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial", J INTERN M, 247(6), 2000, pp. 657-666
99. Gronnerod, TA; von Berg, A; Schwabe, G; Soliman, S
    Formoterol via Turbuhaler (R) gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents
    RESPIRATORY MEDICINE
    
    T.A. Gronnerod et al., "Formoterol via Turbuhaler (R) gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents", RESP MED, 94(7), 2000, pp. 661-667
100. Howarth, PH; Beckett, P; Dahl, R
     The effect of long-acting beta(2)-agonists on airway inflammation in asthmatic patients
     RESPIRATORY MEDICINE
     
     P.H. Howarth et al., "The effect of long-acting beta(2)-agonists on airway inflammation in asthmatic patients", RESP MED, 94, 2000, pp. S22-S25